Advertisement

Cardiology General

Femoropopliteal Artery Interventions: Determinants of Drug-coated Balloon Failure

Oct 31, 2022

Femoropopliteal artery disease is routinely treated using drug-coated balloons (DCB). However, patency loss happens in ≥10% of patients within a year of therapy, and the underlying processes are poo...

Reduced blood pressure in malignant left ventricular hypertrophy patients

Oct 28, 2022

A significant risk of heart failure and mortality is linked to left ventricular hypertrophy (LVH) accompanied by increases in cardiac biomarkers suggesting myocardial damage and neurohormonal stress (...

Abbreviated APT After Coronary Stenting in HBR Myocardial Infarction Patients

Oct 28, 2022

It was unknown how long patients with acute coronary syndrome and high bleeding risk (HBR) should continue antiplatelet therapy (APT) following coronary stenting. For a study, researchers sought to ex...

Left Bundle Branch Vs. Biventricular Pacing for CRT

Oct 28, 2022

The fastest-growing conduction system pacing method that can treat intrinsic left bundle branch block (LBBB) is called left bundle branch pacing (LBBP). As a result, it may be the best substitute for ...

Population-Based Recalibration of the FRS and PCEs

Oct 28, 2022

In many current cohorts, the Framingham Risk Score (FRS) and Pooled Cohort Equations (PCEs) overstate the risk. For a study, researchers sought to determine whether risk stratification for statin medi...

Hemodynamic & Clinical Performance of DCD Hearts

Oct 28, 2022

Heart transplantation continues to experience a shortage of donor organs. Heart donors may be more readily available for individuals with advanced heart failure if donation after circulatory death (DC...

Dapagliflozin in Patients With Heart Failure & LVEF

Oct 28, 2022

Heart failure (HF) patients who have recently been hospitalized are at significant risk of dying and being readmitted. For a study, individuals with HF with modestly decreased or retained left ventric...

Cardiac Structure and Function After Bariatric Surgery

Oct 21, 2022

Although studies with short-term follow-up have shown that weight loss (WL) has positive benefits on the heart, there was limited data on the long-term or long-term consequences of visceral fat reduct...

Aspirin for Primary Prevention of Cardiovascular Events

Oct 20, 2022

Aspirin's potential contribution to the primary prevention of lipoprotein(a)-mediated atherothrombotic events was unknown. In the context of primary prevention, researchers, for a study, examined the ...

Peripartum Screening: Postpartum Hypertension in HDP Women

Oct 20, 2022

Women who have a history of hypertensive disorders of pregnancy (HDP) are more at risk for cardiovascular diseases from chronic hypertension (CHT). For a study, researchers sought to evaluate how well...

MYH7-Related Dilated Cardiomyopathy: Natural History

Oct 19, 2022

About 1% to 5% of patients with dilated cardiomyopathy (DCM) have an illness caused by variations in myosin heavy chain 7 (MYH7); however, the clinical features and natural history of MYH7-related DCM...

Impediments to HTx in MELASMT-TL1:m.3243A>G Cardiomyopathy Adults

Oct 19, 2022

The mitochondrial DNA mutation MT-TL1 m.3243A>G causes maternally inherited mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like events (MELAS) syndrome, which frequently affect...

Cardiac Outcomes in Mitochondrial Diseases Adults

Oct 18, 2022

Arrhythmic major adverse cardiac events (MACE) and heart failure (HF) are potential complications in patients with mitochondrial disorders. For a study, researchers sought to calculate the risk of HF ...

Hypertrophic Cardiomyopathy-Related Mortality

Oct 11, 2022

Despite a declining death toll from hypertrophic cardiomyopathy (HCM) in the United States, persisting discrepancies may occur between different demographic groupings. In this study, researchers analy...

Spironolactone Effect in HF with Preserved Ejection Fraction

Oct 11, 2022

American patients with heart failure and a maintained ejection fraction engaged in the TOPCAT trial (Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial) showed ...

NT-proBNP Sequential Evaluation in HF: Vericiguat Efficacy & Clinical Outcomes

Oct 03, 2022

It is yet uncertain how vericiguat will affect sequential levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) or how this might affect clinical consequences. Researchers in this study look...

EHR-Based Deep Learning Prediction of Death or Severe Decompensation

Oct 03, 2022

Despite saving many people's lives with heart failure (HF), surgical, mechanical ventricular support, and cardiac replacement therapies include substantial risks. Despite this early, less selective su...

Biomarkers & Pathophysiologic Processes With HF Congestion

Oct 03, 2022

Although congestion is the primary cause of heart failure (HF) symptoms, its mechanism is poorly understood. The authors' pathway and differential expression investigations aim to discover biological ...

Glycemic Status and BP Changes with Incident Cardiovascular Disease

Sep 27, 2022

Reducing blood pressure (BP) has been shown to have therapeutic benefits, although it is unclear what those benefits are for people with diabetes. The main goal of this study was to determine the prac...

A Study of Cardiac Allograft Vasculopathy in the US after the 2018 Donor Heart Allocation Policy was Implemented

Sep 26, 2022

The goal of this study is to assess whether or not the new donor heart allocation method in the United States reduces the risk of early cardiac allograft vasculopathy (CAV). Cohort research that looks...